We provide you with 20 years of free, institutional-grade data for FREQ stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of FREQ. Explore the full financial landscape of FREQ stock.
| Reported Date | CIK | Ticker | Type |
|---|
Frequency Therapeutics, Inc(NASDAQ:FREQ) 
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells wit...
Website: http://www.frequencytx.com
IPO Price: $14 (Oct 03, 2019)
Full Time Employees: 43
CEO: David L. Lucchino
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about FREQ stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.